Overview

An Investigational Study to Evaluate Experimental Medication BMS-986036 in Participants With Different Levels of Kidney Function

Status:
Completed

Trial end date:
2019-06-24

Target enrollment:

Participant gender:

Summary

This is an investigational study to evaluate the experimental medication BMS-986036 in participants with different levels of kidney function.

Phase:

Phase 1

Details

Lead Sponsor:

Bristol-Myers Squibb